Primary Site >> Liver Cancer
Gene >> CYP24A1
|
|
|
|
|
|---|---|---|---|---|
|
Ref: Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma. PMID: 20345479 |
Ref: Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy. PMID: 22984610 Ref: Marked increase of CYP24A1 mRNA level in hepatocellular carcinoma cell lines following vitamin D administration. PMID: 23155244 |
Ref: Hepatocellular carcinoma cells express 25(OH)D-1alpha-hydroxylase and are able to convert 25(OH)D to 1alpha,25(OH)(2)D, leading to the 25(OH)D-induced growth inhibition. PMID: 26170242 Ref: Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice. PMID: 26589287 |
Ref: [Vitamin D metabolism and signaling in human hepatocellular carcinoma and surrounding non-tumorous liver]. PMID: 27889974 |
Ref: Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. PMID: 29356898 Ref: Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production. PMID: 30326825 |